Regeneron Pharmaceuticals, Inc. (BMV:REGN)
Mexico flag Mexico · Delayed Price · Currency is MXN
13,613
+112 (0.83%)
At close: Mar 2, 2026

Regeneron Pharmaceuticals Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,411,4091,425,7351,596,9631,579,0701,503,0721,353,626
Market Cap Growth
-2.96%-10.72%1.13%5.06%11.04%33.41%
Enterprise Value
1,134,9791,137,2561,272,2451,359,4711,302,3701,174,855
Last Close Price
13613.0013543.6814434.3114607.6613742.7313139.66
PE Ratio
17.4017.5817.3723.6317.768.18
PS Ratio
5.475.525.407.126.334.11
PB Ratio
2.512.532.613.603.403.52
P/TBV Ratio
2.612.642.723.753.543.52
P/FCF Ratio
19.2119.4120.9124.1017.4210.11
P/OCF Ratio
15.7515.9117.3420.3315.379.32
EV/Sales Ratio
4.554.404.306.135.493.57
EV/EBITDA Ratio
15.2414.8813.1917.2812.516.18
EV/EBIT Ratio
17.6317.0614.7319.0013.376.37
EV/FCF Ratio
15.4515.4816.6620.7515.098.78
Debt / Equity Ratio
0.100.100.100.110.120.14
Debt / EBITDA Ratio
0.690.690.630.600.520.29
Debt / FCF Ratio
0.730.730.800.720.630.41
Net Debt / Equity Ratio
-0.51-0.51-0.51-0.52-0.51-0.52
Net Debt / EBITDA Ratio
-3.74-3.74-3.23-2.89-2.17-1.06
Net Debt / FCF Ratio
-3.89-3.89-4.09-3.47-2.61-1.51
Asset Turnover
0.370.370.400.420.450.76
Inventory Turnover
2.532.532.512.512.372.74
Quick Ratio
3.283.283.864.824.162.98
Current Ratio
4.134.134.735.695.063.56
Return on Equity (ROE)
14.87%14.87%15.95%16.26%20.94%54.21%
Return on Assets (ROA)
5.91%5.91%7.31%8.49%11.42%26.39%
Return on Invested Capital (ROIC)
12.54%13.04%18.58%22.38%26.65%60.13%
Return on Capital Employed (ROCE)
10.20%10.20%12.30%14.30%19.20%41.80%
Earnings Yield
5.75%5.69%5.76%4.23%5.63%12.23%
FCF Yield
5.20%5.15%4.78%4.15%5.74%9.89%
Dividend Yield
0.49%0.47%----
Payout Ratio
8.22%8.22%----
Buyback Yield / Dilution
5.65%5.65%-1.23%-0.18%-1.16%2.52%
Total Shareholder Return
6.13%6.12%-1.23%-0.18%-1.16%2.52%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.